N-[4-(aminocarbonyl)phenyl]-4-methoxy-3-nitrobenzamide

Skin sensitisation

Administrative data

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

migrated information: read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: well performed GLP and OECD guideline study adequate for read across

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2010

Report date:

2010

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

GLP compliance:

yes

Type of study:

mouse local lymph node assay (LLNA)

Test material

Test material information

Constituent 1

Reference substance name:

N-[4-(aminocarbonyl)phenyl]-4-nitrobenzamide

EC Number:

298-791-2

EC Name:

N-[4-(aminocarbonyl)phenyl]-4-nitrobenzamide

Cas Number:

93839-21-5

IUPAC Name:

N-(4-carbamoylphenyl)-4-nitrobenzamide

Details on test material:

- Name of test material (as cited in study report): p-Nitrobenzoylaminobenzamid trocken

In vivo test system

Test animals

Species:

mouse

Strain:

CBA

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Test animals: mice, CBA/CaOlaHsd
- Source: Harlan Laboratories B.V., Postbus 6174, 5960 AD Horst / The Netherlands
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 18.6 - 21.8 g
- Housing: group housing
- Diet: pelleted standard diet, ad libitum
- Water: tap water, ad libitum
- Acclimation period: At least 5 days prior to the start of dosing under test conditions after health examination.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 24
- Humidity (%): 35-65
- Photoperiod (hrs dark / hrs light): artificial light 6:00 a.m. - 6:00 p.m.
- Bedding: granulated soft wood bedding

Study design: in vivo (LLNA)

Vehicle:

acetone/olive oil (4:1 v/v)

Concentration:

5, 10 and 25% ( highest test item concentration, which can be technically used)

No. of animals per dose:

4

Details on study design:

RANGE FINDING TESTS:
- Compound solubility: The highest test item concentration which could be technically used was a 25% suspension in acetone/olive oil (4+1) after sonicating.
In the pre-test, two mice were treated once daily by topical application to the dorsal surface of each ear with test item concentrations of 10 or 25% each on three consecutive days. At those concentrations the animals did not show signs of systemic toxicity or local skin irritation.

MAIN STUDY:

TOPICAL APPLICATION:
Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear (left and right) with test item concentrations of 5, 10, and 25% in acetone:olive oil (4+1). The application volume, 25 µL, was spread over the entire dorsal surface (Ø~ 8 mm) of each ear once daily for three consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (control animals).

ADMINISTRATION OF ³H-METHYL THYMIDINE AND DETERMINATION OF INCORPORATED ³H-METHYL THYMIDINE:

Five days after the first topical application, all mice were intraveneously injected into a tail vein with radio-labelled thymidine (³H-methyl thymidine). Approximately five hours after treatment with ³HTdR all mice were sacrificed and the draining lymph nodes were excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed with phosphate buffered saline and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of ³H-methyl thymidine measured in a ß-scintillation counter.
Furthermore, after the lymph nodes had been excised, both ears of the mice were punched at the apical area using a biopsy punch. For each animal both punches were immediately weighed per animal using an analytical balance.

INTERPRETATION OF RAW DATA:

The proliferative response of lymph node cells is expressed as the number of radioactive disintegrations per minute per lymph node (DPM/node) and as the ratio of ³HTdR incorporated into lymph node cells of test lymph nodes relative to that recorded for control lymph nodes (stimulation index). Before DPM/node values were determined, mean scintillation-background DPM was subtracted from test and control raw data. A test item is regarded as a sensitiser in the LLNA if the following criteria are fulfilled:
- First, that exposure to at least one concentration of the test item resulted in an incorporation of ³HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index.
- Second, that the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.

OBSERVATIONS:

In addition to the sensitising reactions the following observations and data were recorded during the test and observation period:
- Mortality / Viability: Once daily (week day) from experimental start to necropsy.
- Body weights:Prior to the first application and prior to treatment with ³HTdR.
- Ear weights: After sacrifice. Biopsy punches were taken from each ear.
- Clinical signs (local / systemic): In the main experiment clinical signs were recorded within 1 hour after each application, and 24 ± 4 hours after the first and second application as well as on the day of preparation. Especially the treatment sites were observed carefully.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Statistics:

The mean values and standard deviations were calculated for body weights. The ANOVA (Dunnett test) was conducted to assess whether the difference is statistically significant between ear weights of test item groups and the negative control (vehicle) group. Statistical significance was at the five per cent level (p<0.05). However, both biological and statistical significance were considered together.

Results and discussion

Positive control results:

The experiment with the positive control substance was performend, using concentrations of 5, 10, and 25% alpha-hexyl cinnamicaldehyde in acetone:olive oil (4:1 v/v) and Stimulation Indices of 1.49, 4.17, and 4.90, were determined. The EC3 value calculated was 7.8%.
The positive control substance alpha-hexyl cinnamic aldehyde was found to be a skin sensitizer under the described conditions, demonstrating the sensitivity and reliability of the experimental technique employed.

In vivo (LLNA)

Results

Results 1

Parameter:

SI

Remarks on result:

other: S.I.: 5% (w/v): 1.57 10% (w/v): 1.22 25% (w/v): 0.85

Results 2

Parameter:

other: disintegrations per minute (DPM)

Remarks on result:

other: DPM per lymph node: 0% (w/v): 515.1 5% (w/v): 811.2 10% (w/v): 626.6 25% (w/v): 440.1

Any other information on results incl. tables

Calculation and results of individual data; Vehicle: acetone/olive oil (4:1 v/v)

Test item concentration % (w/v)	Group	Measurement DPM	Calculation			Result
			DPM-BG a)	number of lymph nodes	DPM per lymph node b)	S.I.
---	BG I	117	---	---	---	---
---	BG II	32	---	---	---	---
---	1	4195	4121	8	515.1	---
5	2	6564	6490	8	811.2	1.57
10	3	5087	5013	8	626.6	1.22
25	4	3595	3521	8	440.1	0.85

BG = Background (1 mL 5% trichloroacetic acid) in duplicate

1 = Control group

2 -4 = Test groups

S.I. = Stimulation Index

a) = The mean value was taken from the figures BG I and BG II

b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled

The EC3 value could not be calculated since all S.I.'s are below the threshold value of 3.

VIABILITY / MORTALITY

No deaths occurred during the study period.

CLINICAL SIGNS

No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.

BODY WEIGHTS

The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.

EAR WEIGHTS

A significant increase in ear weights was observed in all treatment groups compared with the control group.

Applicant's summary and conclusion

Interpretation of results:

not sensitising

Remarks:

Migrated information Criteria used for interpretation of results: expert judgment

Conclusions:

The test item p-Nitrobenzoylaminobenzamid trocken was not a skin sensitizer under the test conditions of this study.

Executive summary:

In this study the test item p-Nitrobenzoylaminobenzamid trocken dissolved in acetone/olive oil (4+1) was assessed for its possible contact allergenic potential. For this purpose a local lymph node assay according to OECD guideline 429 was performed using test item concentrations of 5, 10, and 25%. All treated animals survived the scheduled study period and no signs of systemic toxicity or local skin irritation were observed.

A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentration results in a 3-fold or greater increase in incorporation of ³HTdR compared with concurrent controls, as indicated by the Stimulation Index (S.I.). The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.

In this study Stimulation Indices of 1.57, 1.22, and 0.85 were determined with the test item at concentrations of 5, 10, and 25% in acetone/olive oil (4+1). The EC3 value was not calculated since none of the tested concentrations induced an S.I. greater than 3. A significant increase in the ear punch biopsies was observed in all treatment groups compared with the control group. However, the data showed that the test item did not induce a relevant proliferation in the draining lymph nodes, thus the observed increase was not attributed to a sensitising effect. In conclusion, the test item p-Nitrobenzoylaminobenzamid trocken was not a skin sensitiser under the described conditions.